Go to deals
Healthcare | TMT

Double Helix Biotechnology Dev. has been acquired by Interpublic Group of Companies

Double Helix Bio-Technology Development Ltd. (Double Helix), a leading, global provider of market research and market access services to the pharmaceutical and medical device industries, has been sold to McCann Health, owned by The Interpublic Group of Companies Inc. Financial details of this transaction have not been disclosed.

Founded by Dr Wayne Phillips and based in London, Double Helix not only specializes in the established markets of the US and Europe, but also focuses on emerging markets, providing clients with a truly global perspective. In the past year, Double Helix has performed projects across more than 40 countries for over 30 major pharmaceutical multinational clients. Dr Phillips will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.

McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by The Interpublic Group of Companies Inc.

Oaklins Cavendish, based in the UK, acted as financial advisor to the seller.

Parties

Talk to the deal team

Lord Leigh of  Hurley

Lord Leigh of Hurley

Principal
London, United Kingdom
Oaklins Cavendish

Related deals

Perkbox has been acquired by Great Hill Partners
Private Equity | TMT

Perkbox has been acquired by Great Hill Partners

Molten Ventures has sold Perkbox to Great Hill Partners.

Learn more
Arculus Cyber Security has been acquired by Bridewell
Private Equity | TMT

Arculus Cyber Security has been acquired by Bridewell

The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.

Learn more
PCI Pal has completed an equity raise
Financial Services | TMT

PCI Pal has completed an equity raise

PCI Pal has completed a fundraising. Funds will be allocated towards several key areas, with a significant portion directed towards supporting its continued expansion in the US, focusing on marketing efforts, product marketing and enhancing engagement with key partners.

Learn more